Literature DB >> 21782001

The AR dependent cell cycle: mechanisms and cancer relevance.

Matthew J Schiewer1, Michael A Augello, Karen E Knudsen.   

Abstract

Prostate cancer cells are exquisitely dependent on androgen receptor (AR) activity for proliferation and survival. As these functions are critical targets of therapeutic intervention for human disease, it is imperative to delineate the mechanisms by which AR engages the cell cycle engine. More than a decade of research has revealed that elegant intercommunication between AR and the cell cycle machinery governs receptor-dependent cellular proliferation, and that perturbations in this process occur frequently in human disease. Here, AR-cell cycle interplay and associated cancer relevance will be reviewed.
Copyright © 2011. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782001      PMCID: PMC3641823          DOI: 10.1016/j.mce.2011.06.033

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  187 in total

1.  Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.

Authors:  Rui Henrique; Vera Lúcia Costa; Nuno Cerveira; André Lopes Carvalho; Mohammad Obaidul Hoque; Franclim Ricardo Ribeiro; Jorge Oliveira; Manuel Rodrigues Teixeira; David Sidransky; Carmen Jerónimo
Journal:  J Mol Med (Berl)       Date:  2006-09-22       Impact factor: 4.599

2.  Expression of p27kip1 in prostatic adenocarcinoma.

Authors:  J C Cheville; R V Lloyd; T J Sebo; L Cheng; L Erickson; D G Bostwick; C M Lohse; P Wollan
Journal:  Mod Pathol       Date:  1998-04       Impact factor: 7.842

3.  Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

Authors:  C Huggins; C V Hodges
Journal:  CA Cancer J Clin       Date:  1972 Jul-Aug       Impact factor: 508.702

Review 4.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

5.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

6.  Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells.

Authors:  Ipsita Mallik; Monica Davila; Tenekua Tapia; Brian Schanen; Ratna Chakrabarti
Journal:  Biochim Biophys Acta       Date:  2008-05-21

7.  Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas.

Authors:  J D Brooks; G S Bova; W B Isaacs
Journal:  Prostate       Date:  1995-01       Impact factor: 4.104

8.  Differential expression of cell cycle regulatory molecules and evidence for a "cyclin switch" during progression of prostate cancer.

Authors:  Lisette A Maddison; Wendy J Huss; Roberto M Barrios; Norman M Greenberg
Journal:  Prostate       Date:  2004-03-01       Impact factor: 4.104

9.  Retinoblastoma tumor suppressor status is a critical determinant of therapeutic response in prostate cancer cells.

Authors:  Ankur Sharma; Clay E S Comstock; Erik S Knudsen; Khanh H Cao; Janet K Hess-Wilson; Lisa M Morey; Jason Barrera; Karen E Knudsen
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

10.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

View more
  21 in total

1.  Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.

Authors:  Luciano De Petrocellis; Alessia Ligresti; Aniello Schiano Moriello; Mariagrazia Iappelli; Roberta Verde; Colin G Stott; Luigia Cristino; Pierangelo Orlando; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  A transcriptional repressor co-regulatory network governing androgen response in prostate cancers.

Authors:  Kern Rei Chng; Cheng Wei Chang; Si Kee Tan; Chong Yang; Shu Zhen Hong; Noel Yan Wei Sng; Edwin Cheung
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

Review 3.  AR-dependent phosphorylation and phospho-proteome targets in prostate cancer.

Authors:  Varadha Balaji Venkadakrishnan; Salma Ben-Salem; Hannelore V Heemers
Journal:  Endocr Relat Cancer       Date:  2020-06       Impact factor: 5.678

4.  A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.

Authors:  Loukia G Karacosta; Barbara A Foster; Gissou Azabdaftari; David M Feliciano; Arthur M Edelman
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

5.  Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells.

Authors:  S Sarkar; D L Brautigan; S J Parsons; J M Larner
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

Review 6.  AR function in promoting metastatic prostate cancer.

Authors:  Michael A Augello; Robert B Den; Karen E Knudsen
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  Androgen and Androgen Receptor as Enhancers of M2 Macrophage Polarization in Allergic Lung Inflammation.

Authors:  Mireya Becerra-Díaz; Ashley B Strickland; Aleksander Keselman; Nicola M Heller
Journal:  J Immunol       Date:  2018-10-10       Impact factor: 5.422

8.  Androgen Deprivation Followed by Acute Androgen Stimulation Selectively Sensitizes AR-Positive Prostate Cancer Cells to Ionizing Radiation.

Authors:  Mohammad Hedayati; Michael C Haffner; Jonathan B Coulter; Raju R Raval; Yonggang Zhang; Haoming Zhou; Omar Mian; Emma J Knight; Nina Razavi; Susan Dalrymple; John T Isaacs; Aileen Santos; Russell Hales; William G Nelson; Srinivasan Yegnasubramanian; Theodore L DeWeese
Journal:  Clin Cancer Res       Date:  2016-02-01       Impact factor: 12.531

9.  MAP3K7 Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of CHD1.

Authors:  Leah C Rider; Lindsey U Rodrigues; Lauren K Jillson; Lina Romero; Anis Karimpour-Fard; Cera Nieto; Claire Gillette; Kathleen Torkko; Etienne Danis; Elizabeth E Smith; Rosalie Nolley; Donna M Peehl; M Scott Lucia; James C Costello; Scott D Cramer
Journal:  Mol Cancer Res       Date:  2021-04-12       Impact factor: 5.852

10.  White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft.

Authors:  Xiaoqiang Wang; Desiree Ha; Hitomi Mori; Shiuan Chen
Journal:  J Nutr Biochem       Date:  2020-12-31       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.